Nine Major Approval Decisions To Watch In Early 2022

 
• By Ayisha Sharma

Nine prominent drug candidates are awaiting an FDA approval decision in the next few months. With the help of Biomedtracker's Early 2022 Outlook Report, we take a look at the potential launches likely to shake up the market from HIV to wet AMD.

Exterior view of the headquarters of US Food and Drug Administration (FDA).
First Ever Approvals Are Expected For Some Indications. • Source: Alamy

More from New Products

More from Scrip